Dmitry Balyasny’s Elevance Health ELV Stock Holding History

Dmitry Balyasny’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,300	Closed	-$12M	–	3054
2025 Q4	$12M	Sell	34,300 -3,100	-8%	-$1.05M	0.02%	940
2025 Q3	$12.1M	Buy	37,400 +4,900	+15%	+$1.52M	0.02%	957
2025 Q2	$12.6M	Sell	32,500 -400	-1%	-$161K	0.02%	859
2025 Q1	$14.3M	Sell	32,900 -3,600	-10%	-$1.45M	0.02%	737
2024 Q4	$13.5M	Buy	36,500 +2,200	+6%	+$921K	0.02%	834
2024 Q3	$17.8M	Buy	34,300 +1,000	+3%	+$534K	0.03%	687
2024 Q2	$18M	Buy	33,300 +600	+2%	+$317K	0.03%	643
2024 Q1	$17M	Buy	32,700 +31,200	+2,080%	+$15.5M	0.03%	699
2023 Q4	$707K	Buy	+1,500	New	+$694K	﹤0.01%	1821
2021 Q3	–	Sell	-2,000	Closed	-$764K	–	2068
2021 Q2	$764K	Buy	+2,000	New	+$764K	﹤0.01%	1404

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dmitry Balyasny's ELV Position: Q2 2026 in Review

Dmitry Balyasny reduced its Elevance Health (ELV) stake by 96% in Q2 2026, selling an estimated $94.8M and leaving 9,927 shares worth $3.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Dmitry Balyasny first reported a position in ELV in Q4 2015 and has held it in 32 quarters since. The position peaked at $89.6M in Q2 2024. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Dmitry Balyasny held 9,927 shares of Elevance Health worth $3.84M as of Q2 2026.
Dmitry Balyasny sold 255,733 Elevance Health shares in Q2 2026, an estimated $94.8M.
Elevance Health made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1496 holding.
Dmitry Balyasny first reported a position in Elevance Health in Q4 2015 and has held it in 32 quarters since.
Dmitry Balyasny's Elevance Health position peaked at $89.6M in Q2 2024.
1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.